Navigation Links
New red blood cell simulator invented at Queen Mary
Date:6/28/2013

Engineers from Queen Mary, University of London have developed the world's most precise computer simulation of how red blood cells might travel around the body to help doctors treat people with serious circulatory problems.

Red blood cells have the important task of carrying oxygen around the body but make up less than half of the total blood volume 45 per cent in men and 40 per cent in women.

Understanding how damaged red blood cells might interact with each other or their neighbouring cells could be useful in realising blood flow in patients who are diabetic or have had surgery to address circulation complications, such as stents or artificial hearts.

The simulations, the largest of their kind, take into account the many forces acting on red blood cells as they travel through the blood vessels, which affect how the cells interact and stick to each other. The data gathered for the various flow situations in the simulation match the data gathered from experiments very closely.

John Williams, Professor of Computational Fluid Dynamics at the School of Engineering and Materials Science, said: "At the moment it's difficult to visualise how red blood cells travel through the body as they are very small and hard to track through enclosed vessels such as arteries and the heart. Our research will help medical professionals to visualise the cells movement, interaction, deformation and adhesion in three dimensions.

"This could help doctors in understanding which areas of the body are being starved of oxygen in patients who have had heart surgery, for example."

Professor Williams added: "Because of the enormous number of cells involved, we need vast supercomputer resources now in order to carry out a simulation of the flow of both damaged and undamaged red blood cells through a stent to study the effects on the cells."

The research is published in the Journal of Biomechanics.


'/>"/>

Contact: Neha Okhandiar
n.okhandiar@qmul.ac.uk
020-788-27927
Queen Mary, University of London
Source:Eurekalert

Page: 1

Related biology technology :

1. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
2. China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2013 Financial Results
3. Cellular Therapy and Cord Blood 2013 Market Report
4. Alzheimers Leaves Clues in Blood
5. Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA
6. Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science
7. New York Blood Centers Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development
8. BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
9. Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager Launches Educational Meetings for General Public on Umbilical Cord Blood Stem Cells
10. A Blood Sample Predicts if Cancer Patients Respond to Therapy
11. Save The Cord Foundation, a Global Leader in Cord Blood Advocacy, Announces its Expansion of Educational Information Surrounding Other Non-Controversial Stem Cell Sources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
Breaking Biology News(10 mins):